Also consistent with prior reports, the serum level of Gd-IgA1 for the IgAN patients was significantly higher compared to that for the CKD controls (P<0.001) and healthy controls (P<0.001) (Figure 1A). This evidence concerns the gene IGHA1 and chronic kidney disease.